Jean DePamphilis

931 total citations
15 papers, 700 citations indexed

About

Jean DePamphilis is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Jean DePamphilis has authored 15 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 2 papers in Rheumatology. Recurrent topics in Jean DePamphilis's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Jean DePamphilis is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Jean DePamphilis collaborates with scholars based in United States, Germany and Australia. Jean DePamphilis's co-authors include Douglas T. Dieterich, Francesca J. Torriani, Robert Reindollar, Gregory T. Everson, Mitchell Shiffman, Coleman I. Smith, Amy Lin, K. Rajender Reddy, Preston P. Purdum and Michael Fried and has published in prestigious journals such as Gastroenterology, Hepatology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jean DePamphilis

15 papers receiving 665 citations

Peers

Jean DePamphilis
W. Graham E. Cooksley Australia
Bach Nga Pham France
Galia Askarieh Sweden
Joann Harvey United States
T Sodeyama Japan
M. Peck United Kingdom
M. Willems Belgium
Ronny Cicola Italy
E Dussaix France
Georg Goldmann Germany
W. Graham E. Cooksley Australia
Jean DePamphilis
Citations per year, relative to Jean DePamphilis Jean DePamphilis (= 1×) peers W. Graham E. Cooksley

Countries citing papers authored by Jean DePamphilis

Since Specialization
Citations

This map shows the geographic impact of Jean DePamphilis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean DePamphilis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean DePamphilis more than expected).

Fields of papers citing papers by Jean DePamphilis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean DePamphilis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean DePamphilis. The network helps show where Jean DePamphilis may publish in the future.

Co-authorship network of co-authors of Jean DePamphilis

This figure shows the co-authorship network connecting the top 25 collaborators of Jean DePamphilis. A scholar is included among the top collaborators of Jean DePamphilis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean DePamphilis. Jean DePamphilis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sievert, William, Gregory J. Dore, Geoffrey W. McCaughan, et al.. (2011). Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. Hepatology. 53(4). 1109–1117. 29 indexed citations
2.
Rodríguez‐Torres, M., Francesca J. Torriani, JK Rockstroh, et al.. (2010). Degree of Viral Decline Early in Treatment Predicts Sustained Virological Response in HCV-HIV Coinfected Patients Treated with Peginterferon Alfa-2a and Ribavirin. HIV Clinical Trials. 11(1). 1–10. 5 indexed citations
3.
Rodríguez‐Torres, M., Francesca J. Torriani, Jürgen K. Rockstroh, et al.. (2010). Degree of Viral Decline Early in Treatment Predicts Sustained Virological Response in HCV-HIV Coinfected Patients Treated with Peginterferon Alfa-2a and Ribavirin. HIV Clinical Trials. 11(1). 1–10. 1 indexed citations
4.
Roberts, Stuart K., Martin Weltman, Dorothy H. Crawford, et al.. (2009). Impact of High-Dose Peginterferon Alfa-2A on Virological Response Rates in Patients with Hepatitis C Genotype 1: a Randomized Controlled Trial† ‡. Hepatology. 50(4). 1045–1055. 50 indexed citations
5.
Cheng, Wenwen, Stuart K. Roberts, Martin Weltman, et al.. (2009). 601 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A 360 μG/WEEK IN COMBINATION WITH RIBAVIRIN IN HEPATITIS C GENOTYPE 1 PATIENTS WITH CIRRHOSIS: ANALYSIS FROM THE CHARIOT STUDY. Journal of Hepatology. 50. S221–S221. 3 indexed citations
6.
Opravil, Milos, Joe Sasadeusz, David A. Cooper, et al.. (2008). Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(1). 36–49. 46 indexed citations
7.
Rodríguez‐Torres, M., Sugantha Govindarajan, Ricard Solà, et al.. (2008). Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study. Journal of Hepatology. 48(5). 756–764. 29 indexed citations
8.
Crawford, Dorothy H., Stuart K. Roberts, Martin Weltman, et al.. (2008). 779 BASELINE FACTORS ASSOCIATED WITH RAPID AND EARLY VIROLOGICAL RESPONSES IN HCV GENOTYPE 1 PATIENTS TREATED WITH INDUCTION DOSING OF PEGYLATED INTERFERON: THE CHARIOT STUDY. Journal of Hepatology. 48. S290–S291. 2 indexed citations
9.
Rodríguez‐Torres, M., Juan González‐García, Norbert Bräu, et al.. (2007). Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem?. Journal of Medical Virology. 79(6). 694–700. 30 indexed citations
10.
Lissen, Eduardo, Nathan Clumeck, R. Solà, et al.. (2006). Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection. AIDS. 20(17). 2175–2181. 38 indexed citations
11.
Mauss, Stefan, William M. Valenti, Jean DePamphilis, et al.. (2004). Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS. 18(13). 21–25. 123 indexed citations
12.
Reddy, K. Rajender, Teresa L. Wright, Paul J. Pockros, et al.. (2001). Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C. Hepatology. 33(2). 433–438. 284 indexed citations
13.
14.
Eron, Lawrence J., et al.. (1993). Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon.. Sexually Transmitted Infections. 69(2). 91–93. 26 indexed citations
15.
Brady, Michael T., S D Sears, Davide Pacini, et al.. (1990). Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrobial Agents and Chemotherapy. 34(9). 1633–1636. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Graham E. Cooksley Breakdown of academic impact, for papers by Bach Nga Pham Breakdown of academic impact, for papers by Galia Askarieh Breakdown of academic impact, for papers by Joann Harvey Breakdown of academic impact, for papers by T Sodeyama Breakdown of academic impact, for papers by M. Peck Breakdown of academic impact, for papers by M. Willems Breakdown of academic impact, for papers by Ronny Cicola Breakdown of academic impact, for papers by E Dussaix Breakdown of academic impact, for papers by Georg Goldmann
Rankless by CCL
2026